Kiyoshi Ichikawa
Pharmacological Laboratories
Kissei Pharmaceutical Co.
Ltd, Hotaka
Nagano
Japan
Name/email consistency: high
- Effect of KAD-1229, a novel hypoglycaemic agent, on plasma glucose levels after meal load in type 2 diabetic rats. Ichikawa, K., Yamato, T., Ojima, K., Tsuji, A., Ishikawa, K., Kusama, H., Kojima, M. Clin. Exp. Pharmacol. Physiol. (2002)
- Study of the insulinotropic effect of the novel antihyperglycemic agent KAD-1229 using HIT T15 cells, a hamster's insulinoma cell line. Ichikawa, K., Yamato, T., Tsuji, A., Ojima, K., Kusama, H., Kojima, M. Arzneimittelforschung (2002)
- Inhibitory effect of oxcarbazepine on high-frequency firing in peripheral nerve fibers. Ichikawa, K., Koyama, N., Kiguchi, S., Kojima, M., Yokota, T. Eur. J. Pharmacol. (2001)
- Absence of exacerbation of myocardial stunning in anesthetized dogs treated with KAD-1229, a novel hypoglycemic agent. Ichikawa, K., Maruyama, K., Murakami, M., Tsuji, A., Yamato, T., Kusama, H., Kojima, M. Eur. J. Pharmacol. (2001)
- Effect of ozagrel on locomotor and motor coordination after transient cerebral ischemia in experimental animal models. Ichikawa, K., Tazawa, S., Hamano, S., Kojima, M., Hiraku, S. Pharmacology (1999)